Impact of Education Delivered Through Virtual Platforms on the Awareness of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Among Families in Fars Province, Iran

Document Type : Original Article

Authors

1 HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

2 Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3 Non-communicable Disease Prevention Group, Vice Chancellor of Health, Shiraz University of Medical Sciences, Shiraz, Iran

4 Research Center for Youth Population and Active Aging, Shiraz University of Medical Sciences, Shiraz, Iran

10.34172/jhad.1230

Abstract

Introduction: Despite the high prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Iran, public awareness of the disease remains underexplored. This study aimed to evaluate the effect of a virtual educational intervention on parents’ awareness of G6PD deficiency in Shiraz, Fars Province.
Methods: This one-group, prospective, quasi-experimental study was conducted on 100 parents of children diagnosed with G6PD deficiency through the neonatal screening program at Shiraz University of Medical Sciences. A researcher-designed checklist was used to assess participants’ awareness of G6PD deficiency before and after the educational intervention, delivered via smartphone applications. Statistical analysis was performed to determine the effect of the intervention on participants’ knowledge, with results considered significant at P < 0.05.
Results: Fewer than half of the participants demonstrated sufficient awareness of neonatal G6PD deficiency screening. Before the intervention, participants showed limited awareness of the disease, its manifestations, and foods or drugs to avoid. The educational intervention delivered through virtual platforms significantly improved participants’ awareness across all domains (P < 0.001). The greatest improvements were observed in the domains of general awareness about the disease (mean paired difference = 2.09; SD = 1.33) and disease manifestations (mean paired difference = 2.04; SD = 1.54).
Conclusion: Despite the high prevalence of G6PD deficiency in Iran, public awareness of the condition remains inadequate. Implementing effective educational tools and expanding health education through accessible virtual platforms are essential for increasing awareness and improving disease prevention strategies.

Keywords

Main Subjects

References

  1. Moosazadeh M, Amiresmaili M, Aliramezany M. Prevalence of G6PD deficiency in Iran, a mata-analysis. Acta Med Iran 2014;52(4):256-64.
  2. Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A, Cheah FC. Glucose-6-phosphate dehydrogenase deficiency and neonatal hyperbilirubinemia: insights on pathophysiology, diagnosis, and gene variants in disease heterogeneity. Front Pediatr 2022;10:875877. doi:3389/fped.2022.875877
  3. Iranpour R, Hashemipour M, Talaei SM, Soroshnia M, Amini A. Newborn screening for glucose-6-phosphate dehydrogenase deficiency in Isfahan, Iran: a quantitative assay. J Med Screen 2008;15(2):62-4. doi:1258/jms.2008.008027
  4. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371(9606):64-74. doi:1016/s0140-6736(08)60073-2
  5. Davoudi Kiakalayeh A, Darbandi B, Davoudi-Kiakalayeh. Mapping of favism and G6PD disease in Iran: a mini review. Iran J Blood Cancer 2024;16(3):48-54.
  6. Kosaryan M, Mahdavi MR, Jalali H, Roshan P. Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants? Pediatr Hematol Oncol 2014;31(1):95-100. doi:3109/08880018.2013.871613
  7. Kamali M, Mehralizadeh A, Taheri Sarvtin M. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Jiroft city in southern Iran. Int J Med Lab 2022;9(2):81-4. doi:18502/ijml.v9i2.10016
  8. Saadat SH, Naderi S, Zare S, Khalili S, Darban B, Goodarzi R. Epidemiologic study of jaundice in newborns with jaundice in the first 24 hours of birth in children’s hospital and Shariati hospital of Bandar Abbas in 2010-2014. J Res Med Dent Sci 2018;6(1):113-7. doi:24896/jrmds.20186118
  9. Javadi M, Deravi S, Zarei S, Mahdavi N, Ranjbaran M. Prevalence of G6PD deficiency in Iranian neonates with jaundice: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2022;35(25):5813-20. doi:1080/14767058.2021.1895738
  10. Patel J, Almeida H, Alhadad SZ, Pinto AC, Foley M, Al-Lamee R. Digital app reshaping cardiac rehabilitation: a pilot study. Future Healthc J 2023;10(Suppl 3):15-7. doi:7861/fhj.10-3-s15
  11. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ 1989;67(6):601-11.
  12. Darbandi B, Noghbaei M, Mehrabian F, Jafroodi M. Medical expenses of patients with Favism admitted to 17th Shahrivar Hospital compared to G6PD enzyme screening cost, in north of Iran. Iran J Ped Hematol Oncol 2014;4(2):53-6.
  13. Rezabeigi Davarani E, Mohseni Takaloo F, Daneshi S, Sanjari P, Khanjani N, Hushmandi K, et al. Assessing the phenylketonuria (PKU) neonatal screening program and the incidence rates of PKU in Kerman county, Iran: a health system research. J Pediatr Neonatal Individ Med 2022;11(2):e110217. doi:7363/110217
  14. Ganji F, Naseri H, Rostampour N, Sedighi M, Lotfizadeh M. Assessing the phenylketonuria screening program in newborns, Iran 2015-2016. Acta Med Iran 2018;56(1):49-55.
  15. Zahed Pasha Y, Alizadeh-Tabari S, Zahed Pasha E, Zamani M. Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis. World J Pediatr 2020;16(5):480-93. doi:1007/s12519-020-00339-3
  16. Hemmati F, Mahini SM, Bushehri M, Asadi AH, Barzegar H. Exchange transfusion trends and risk factors for extreme neonatal hyperbilirubinemia over 10 years in Shiraz, Iran. Iran J Med Sci 2024;49(6):384-93. doi:30476/ijms.2023.99176.3123
  17. Kamali M, Taheri Sarvtin M. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in patients suspected of favism in Qaleh Ganj, southern Iran: a restriction for malaria elimination. J Mazandaran Univ Med Sci 2022;32(209):180-5.
  18. Pahlavanzadeh M, Hekmatimoghaddam S, Teremahi Ardestani M, Ghafoorzadeh M, Aminorraaya M. G6PD enzyme deficiency in neonatal pathologic hyperbilirubinemia in Yazd. Iran J Ped Hematol Oncol 2013;3(2):69-72.
  19. Hatam N, Shirvani S, Javanbakht M, Askarian M, Rastegar M. Cost-utility analysis of neonatal screening program, Shiraz University of Medical Sciences, Shiraz, Iran, 2010. Iran J Pediatr 2013;23(5):493-500.
  20. Potluri TS, Vadlamani S, Gujjarlapudi C, Nerusu NG, Rongala MV. An educational intervention study to enhance breast cancer awareness among women and primary healthcare providers of an urban health center area, Visakhapatnam. J Family Med Prim Care 2023;12(8):1697-703. doi:4103/jfmpc.jfmpc_932_23
  21. Kizilkaya MC, Kilic S, Dagistanli S, Eren MF, Basaran C, Ohri N, et al. Effectiveness of a telehealth patient education intervention for breast cancer awareness and screening uptake among Afghan refugee women: a cross-sectional survey and feasibility study. EClinicalMedicine 2023;62:102094. doi:1016/j.eclinm.2023.102094
  22. Choi H, Dion H, Huang M, Sathyan L, Herfel E, Makhulo B, et al. Applying the Information-Motivation-Behavioral Skills model to a video-assisted HPV intervention to promote self-screening uptake: a qualitative study in Western Kenya. BMJ Glob Health 2025;10(5). doi:1136/bmjgh-2024-017616
  23. Golnam M, Hassani L, Goodarzi RS, Ghanbarnejad A. The effectiveness of a theory‑based health education program on self-efficacy and breastfeeding behaviors continuity of working mothers in Iran. Sci Rep 2025;15(1):5625. doi:1038/s41598-025-89943-9
  24. Alsalami OA, Kamel S, Almatrafi RS, Alalwani BM, Alanazi AI, Algarni AD, et al. Enhancing self-hygiene awareness and practices during menstruation among female adolescent students in Saudi Arabia: a comprehensive educational program initiative. Cureus 2025;17(9):e91541. doi:7759/cureus.91541
  25. Demianiuk S, Rutkowska A, Piskorska E, Tomaszewska A. Can a comic book superhero protect us from diseases? Assessment of an educational tool on immunizations among adolescents. Przegl Epidemiol 2025;79(2):250-62. doi:32394/pe/206926
  26. Ragab Mahmoud SK, Ahmed SM, Abo El-Wafa NF, Mohammed ZH. Mothers’ knowledge and reported practices about care provided for their children having favism. Minia Sci Nurs J 2023;14(1):32-41.
  27. Gad El-Bastwese RM, Mahmous Sabea MT, Elsamanoudy MI. Health education program for mothers their children diagnosed with favism. Assiut Sci Nurs J 2020;8(23):67-75.
  28. Fahiem A, Eldin MA. Mothers’ perception for their children suffering from favism. Helwan Int J Nurs Res Pract 2024;3(7):75-91.
  29. Meloni T, Forteleoni G, Meloni GF. Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience. Acta Haematol 1992;87(1-2):29-31. doi:1159/000204709
Health and Development Journal
Volume 14, Issue 1
May 2025
Pages 1-5

Files

History

  • Receive Date: 20 May 2025
  • Revise Date: 01 July 2025
  • Accept Date: 26 November 2025

Share

How to cite

Statistics